[email protected] +1 646 480 7505 (U.S.) | +44 203 318 2846 (U.K.)

TABLE OF CONTENTS

1          Introduction

1.1       Market Definition

1.2       Market Scope

2          Research Methodology

2.1       Primary Research

2.2       Research Methodology

2.3       Assumptions & Exclusions

2.4       Secondary Data Sources

3          Market Overview

3.1       Report Segmentation & Scope

3.2       Value Chain Analysis: Dry Eye Syndrome Market

3.3       Key Market Trends

3.3.1    Drivers

3.3.2    Restraints

3.3.3    Opportunities

3.4       Porter’s Five Forces Analysis

3.4.1    Bargaining Power of Suppliers

3.4.2    Bargaining Power of Buyers

3.4.3    Threat of Substitution

3.4.4    Threat of New Entrants

3.4.5    Competitive Rivalry

3.5       Market Share Analysis

4          By Type Overview

4.1       Introduction

4.1.1    Market Size & Forecast (Value)

4.2       Evaporative Dry eye syndrome

4.3       Aqueous Dry eye syndrome

5        By Treatment Type Overview

5.1       Introduction   

5.1.1    Market Size & Forecast (Value)

5.2       Nutritional Supplements

5.3       Serum Eye Drops

5.4       Lubricant Eye Drops

5.4.1    Oily Tear Eye Drops

5.4.2    Ointments

5.4.3    Preservative-Free drops

5.5       Anti-inflammatory drugs Segments

5.5.1    Tetracyclines

5.5.2    Corticosteroids

6          Regional Overview

6.1       Introduction

6.1.1    Market Size & Forecast (Value)

6.2       America

6.2.1    North America

6.2.1.1 U.S.

6.2.1.1.1          By Type

6.2.1.1.2           By Treatment Type  

6.2.1.2 Canada

6.2.1.2.1          By Type

6.2.1.2.2          By Treatment Type

6.2.1.3 Mexico

6.2.1.3.1          By Type

6.2.1.3.2          By Treatment Type

6.2.2    Latin America

6.2.2.1 By Type

6.2.2.2 By Treatment Type

6.3       Europe

6.3.1    Market Size & Forecast (Value)

6.3.2    Germany

6.3.2.1 By Type

6.3.2.2 By Treatment Type

6.3.3    France

6.3.3.1 By Type

6.3.3.2 By Treatment Type

6.3.4    U.K.

6.3.4.1 By Type

6.3.4.2 By Treatment Type

6.3.5    Italy

6.3.5.1 By Type

6.3.5.2 By Treatment Type

6.3.6    Spain

6.3.6.1 By Type

6.3.6.2 By Treatment Type

6.3.7    Rest of Europe

6.3.7.1 By Type

6.3.7.2 By Treatment Type

6.4       Asia Pacific

6.4.1    Market Size & Forecast (Value)

6.4.2    Japan

6.4.2.1 By Type

6.4.2.2 By Treatment Type

6.4.3    China

6.4.3.1 By Treatment Type

6.4.3.2 By Treatment Type

6.4.4    Australia

6.4.4.1 By Type

6.4.4.2 By Treatment Type

6.4.5    India

6.4.5.1 By Type

6.4.5.2 By Treatment Type

6.4.6    South Korea

6.4.6.1 By Type

6.4.6.2 By Treatment Type

6.4.7    Rest of Asia-Pacific

6.4.7.1 By Type

6.4.7.2 By Treatment Type

6.5       Middle East & Africa

6.5.1    Market Size & Forecast (Value)

6.5.2    Saudi Arabia

6.5.2.1 By Type

6.5.2.2 By Treatment Type

6.5.3    South Africa

6.5.3.1 By Type

6.5.3.2 By Treatment Type

6.5.4    Kuwait

6.5.4.1 By Type

6.5.4.2 By Treatment Type

6.5.5    Rest of Middle East & Africa

6.5.5.1 By Type

6.5.5.2 By Treatment Type

7.         Company Profile

7.1       Allergan

7.1.1    Company Overview

7.1.2    Financial Performance

7.1.3    Recent Developments

7.1.4    Product Portfolio

7.2       Alcon

7.2.1    Company Overview

7.2.2    Financial Performance

7.2.3    Recent Developments

7.2.4    Product Portfolio

7.3       Santen Pharmaceutical Co. Ltd.

7.3.1    Company Overview

7.3.2    Financial Performance

7.3.3    Recent Developments

7.3.4    Product Portfolio

7.4       Shire/SAR code Bioscience

7.4.1    Company Overview

7.4.2    Financial Performance

7.4.3    Recent Developments

7.4.4    Product Portfolio

7.5       Otsuka Holdings

7.5.1    Company Overview

7.5.2    Financial Performance

7.5.3    Recent Developments

7.5.4    Product Portfolio

7.6       Can-Fite Biopharma

7.6.1    Company Overview

7.6.2    Financial Performance

7.6.3    Recent Developments

7.6.4    Product Portfolio

7.7       Novartis

7.7.1    Company Overview

7.7.2    Financial Performance

7.7.3    Recent Developments

7.7.4    Product Portfolio

7.8       Eyegate Pharma.

7.8.1    Company Overview

7.8.2    Financial Performance

7.8.3    Recent Developments

7.8.4    Product Portfolio



Request For Free Sample
Choose license Type

Buy Chapters or Sections

Avail customized purchase option to meet your exact research needs:

1)Buy sections of the report
2)Buy country level report
3)Request for historical data

Request a Free Sample   Special Pricing
Related Reports